• Non ci sono risultati.

View of Transcranial direct current stimulation improves myofascial pain syndrome and chronic fatigue

N/A
N/A
Protected

Academic year: 2021

Condividi "View of Transcranial direct current stimulation improves myofascial pain syndrome and chronic fatigue"

Copied!
3
0
0

Testo completo

(1)

Dear Editor,

Myofascial pain syndrome (MPS) is usually accompanied by fatigue, mood al- terations, and impaired quality of life (1).

MPS treatments include pharmacological regimens (e.g., analgesics, muscle relax- ants) and non-pharmacological schemes (e.g., exercise training, physiotherapy, acu- puncture). Most of these strategies can also be applied to the treatment of fatigue. In addition, transcranial direct current stimu- lation (tDCS) has been used with good outcomes in individuals with MPS (1, 2) or fatigue (3, 4). The tDCS is safe with no serious adverse effects, and can reserve the central pain pathway by modulating cortical plasticity (2-4). To the best of our knowledge, no studies have assessed the ef- fects of tDCS in patients with both refrac- tory MPS and chronic fatigue.

In this context, we assessed a 33-year-old non-sedentary female patient with refrac- tory MPS and fatigue, which had lasted for two years. She had received several thera- pies, such as gabapentin, amitriptyline, acupuncture, and Pilates exercises, which consists of low-impact flexibility and mus- cle strength exercises, and improve the overall body coordination. At admission to our service, she had a trigger point in her right quadratus lumborum, which radi- ated pain throughout the gluteus medius.

Moreover, she had a trigger point in her left sternocleidomastoid, trapezius, levator scapulae, and posterior cervical muscles, which caused radiating pain throughout to

her entire left arm and shoulder. These trig- ger points were defined as sensitive spots and were located in a taut band of skeletal muscles. They caused local pain and re- ferred muscle pain.

After signing the informed consent, the pa- tient underwent five consecutive tDCS ses- sions with 2mA for 20 minutes. The pos- itively-charged electrode was positioned at C3 (contralateral to the dominant limb), while the negatively-charged electrode was placed in the supraorbital region FP2.

During the tDCS sessions, the patient per- formed also some physical exercise, which included a 5-minute treadmill warm-up followed by lower intensity (5) strength exercises: bench press, bench-squat, cable seated row, and leg press at 45º (three sets of 10-12 repetitions with breaks between 45 and 60 seconds).

At baseline (PRE) and after five days (POST), the patient completed the follow- ing questionnaires: Pain Quality Assess- ment Scale (PQAS) (6), McGill pain inven- tory (7), Fatigue Severity Scale (FSS) (8), and Short Form-36 (9). The data were ex- pressed as percentages (%) of change: (the difference between post and pre-values)/

pre-value.

Compared to the PRE phase, myofas- cial pain decreased in the POST phase, as shown through the PQAS and McGill pain inventory questionnaires (Figure 1A and 1B). Moreover, notable improvements were observed in all the domains of quality of life (Figure 1C). In addition, there was a

Transcranial direct current stimulation improves myofascial pain syndrome and chronic fatigue

R.G. Misse, A.M. dos Santos, J.M. de Souza, S.K. Shinjo

Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Corresponding author:

Samuel Katsuyuki Shinjo Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Avenida Dr. Arnaldo, 455 - 3º andar, sala 3150, Cerqueira Cesar, CEP 01246-903, SP, Brazil E-mail: [email protected] 186 Reumatismo 3/2020

Reumatismo, 2020; 72 (3): 186-188

LETTER TO THE EDITOR

Non-commercial

use only

(2)

Reumatismo 3/2020 187 Transcranial direct current stimulation improves myofascial pain syndrome

LETTER

TO THE EDITOR

mild reduction in the FSS parameters: 6.1 vs. 5.7 (–6.6%). There was no adverse ef- fect related to tDCS and exercise training, and the patient participated in all phases of the protocol.

According to the literature, our patient had a good outcome with tDCS associated with exercise training: pain and fatigue de- creased and quality of life also improved.

These results can be related to the im- pact on the maladaptive efferent feedback mechanism present in pain, which leads to consequent reduction of fatigue (4).

These results are promising, but further

studies with a larger sample size are neces- sary to confirm our findings.

Funding

This work was funded by: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) #2019/12155-5 to RGM,

#2018/08735-3to AMS, and #2019/11776- 6 to SKS; Conselho Nacional de De- senvolvimento Científico e Tecnológico (CNPq) 303379/2018-9 to SKS; Faculdade de Medicina da USP to SKS.

Conflict of interest

All authors declare no conflict of interest.

Figure 1 - Data related to McGill pain assessment (A), health quality of life (B), and (C) general pain quality assessment. The data were expressed as percentages (%) of change: (the difference between post and pre-values)/pre-value.

B A

C

Non-commercial

use only

(3)

LETTER TO THE EDITOR

188 Reumatismo 3/2020

R.G. Misse, A.M. dos Santos, J.M. de Souza, et al.

LETTER TO THE EDITOR

n REFERENCES

1. Saxena A, Chansoria M, Tomar G, Kumar A.

Myofascial pain syndrome: an overview. J Pain Palliative Care Pharmacother. 2015; 29:

16-21.

2. Fagerlund AJ, Hansen OA, Aslaksen, PM.

Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain. 2015; 156;

62-71.

3. Choi YH, Jung SJ, Lee CH, Lee SU. Addition- al effects of transcranial direct-current stimu- lation and trigger-point injection for treatment of myofascial pain syndrome: a pilot study with randomized, single-blinded trial. J Altern Complem Med. 2014; 20: 698-704.

4. Lefaucheur JP, Chalah MA, Mhalla A, Palm U, Ayache SS, Mylius V. The treatment of fa- tigue by non-invasive brain stimulation. Neu- rophysiologie Clinique. 2017; 47: 173-184.

5. Borg G. Psychophysical scaling with applica- tions in physical work and the perception of exertion. Scand J Work Environ Health. 1990;

16: 55-58.

6. Carvalho AB, Garcia JBS, Silva TKM, Ribei- ro JVF. Tradução e adaptação transcultural da Pain Quality Assessment Scale (PQAS) para a versão brasileira. Braz J Anesthesiol. 2016;

66: 94-104.

7. Melzack R. The McGill Pain Questionnaire:

major properties and scoring methods. Pain.

1975; 1: 277-99.

8. Krupp LB, LaRocca NG, Muir-Nash J, Stein- berg AD. The fatigue severity scale. Applica- tion to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol.

1989; 46: 1121-3.

9. Da Mota Falcão D, Ciconelli RM, Ferraz MB.

Translation and cultural adaptation of quality of life questionnaires: an evaluation of meth- odology. J Rheumatol. 2003; 30: 379-85.

Non-commercial

use only

Riferimenti

Documenti correlati

Stage III: In patients who develop chronic pain, the nervous system continues to send signals for pain and muscle spasm as though in response to an acute injury, even though the

Per la valutazione della semantica del dolore nel- la Divina Commedia sono stati considerati come riferimento i descrittori del dolore contenuti nella versione italiana del McGill

Even though the global pain intensity was similar between groups, the findings suggest that the FM group pre- sented the worst pain experience and a lower health-related quality of

Efficacy and safety of tapentadol extended release com- pared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of

Inflammatory pain symptoms can be reduced by non-steroidal anti-inflammatory drugs, but many patients continue to experience moderate pain due to alterations in the mechanisms

It is therefore crucial to take a thorough medical history concerning the duration of the pain, its characteristics, previous treatments, al- lergies, surgery, sexual activity,

These drugs are effective alone for mild to moderate pain and have a synergistic effect when used in combina- tion with opioids for severe pain.. They are nonaddictive,

Table 1 - In vitroandin vivopharmacological activities of TRPV1 antagonists AntagonistIn vitroReferencesIn vivoReferences Capsazepine↓CAP response in rat DRG